Patent: 10,316,282
✉ Email this page to a colleague
Summary for Patent: 10,316,282
Title: | Method for producing a product (e.g. polypeptide) in a continuous cell culture fermentation process |
Abstract: | A method for improving productivity in microbial fermentations and mammalian cell culture bioreactors. |
Inventor(s): | Laustsen; Mads (Gentofte, DK) |
Assignee: | CMC BIOLOGICS A/S (Soborg, DK) |
Application Number: | 14/778,222 |
Patent Claims: | see list of patent claims |
Details for Patent 10,316,282
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Grifols Therapeutics Llc | KOATE, KOATE-DVI | antihemophilic factor (human) | For Injection | 101130 | 01/24/1974 | ⤷ Try a Trial | 2033-03-19 |
Baxalta Us Inc. | HEMOFIL M | antihemophilic factor (human) | For Injection | 101448 | 03/14/2001 | ⤷ Try a Trial | 2033-03-19 |
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | ⤷ Try a Trial | 2033-03-19 |
Novartis Pharmaceuticals Corporation | SIMULECT | basiliximab | For Injection | 103764 | 05/12/1998 | ⤷ Try a Trial | 2033-03-19 |
Novartis Pharmaceuticals Corporation | SIMULECT | basiliximab | For Injection | 103764 | 01/02/2003 | ⤷ Try a Trial | 2033-03-19 |
Swedish Orphan Biovitrum Ab (publ) | SYNAGIS | palivizumab | For Injection | 103770 | 06/19/1998 | ⤷ Try a Trial | 2033-03-19 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |